Litcius/Paper detail

Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways

Kecheng Tang, Bin Zhong, Qingman Luo, Qiao Liu, Xin Chen, Dayan Cao, Xiaohui Li, Shengqian Yang

2022European Journal of Pharmacology44 citationsDOI

Topics & Concepts

Protein kinase Bp38 mitogen-activated protein kinasesInternal medicineMAPK/ERK pathwayEndocrinologyMuscle hypertrophyProinflammatory cytokinePhosphorylationNF-κBMedicineChemistryPharmacologyBiologyInflammationCell biologyPhytochemistry and Biological ActivitiesNeuroinflammation and Neurodegeneration MechanismsBioactive natural compounds
Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways | Litcius